ZYVERSA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $48 as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-03-25
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $48.00.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $472.00.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.31K.
- 2023-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.55K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2023-12-31 | $48.00 10-K · filed 2024-03-25 |
| 2023-09-30 | $472.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.31K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $2.55K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $4.16K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |